慢性阻害性肺疾患 (COPD) の骨粗鬆症に対する吸入用コルチコステロイドの影響: 系統的レビュー
Mona Mohammednoor1, Ahmed Mohamed Elamin Mubarak Osman2, Saba Hamad3
1Diabetes and Endocrinology, Queen Elizabeth Hospital Birmingham, Birmingham, GBR.
Cureus
|September 2, 2025
まとめ
COPDに対する吸入用コルチコステロイド (ICS) は,特に高用量または長期使用では,骨粗鬆症および骨折のリスクを増加させる可能性があります. 臨床医は,リスクの高い患者に骨の保護を考慮する必要があります.
科学分野:
- 肺医学
- 骨の健康 研究
- 薬用警戒について
背景:
- 呼吸用コルチコステロイド (ICS) は慢性閉塞性肺疾患 (COPD) の標準薬である.
- 長期にわたるICS使用は,骨粗鬆症や骨折を含む骨の健康に関する懸念を引き起こします.
- COPD患者の骨の合併症とICSを関連付ける証拠は,合成を必要とする.
研究 の 目的:
- COPD患者の骨粗鬆症と骨折リスクに対するICSの影響を体系的に検討する.
- 観察研究と臨床研究から得られた証拠を統合する.
- ICSと骨の健康関係に影響を与える要因を特定する.
主な方法:
- 主要なデータベース (PubMed,Web of Science,Scopus,Embase,Cochrane Library) で体系的な文献検索を行っています.
- 体系的なレビューとメタ分析 (PRISMA) のガイドラインの優先報告項目の遵守
- ニューカッスル・オタワスケール (NOS) を用いてバイアスのリスクを評価した11件の研究から得られたデータをまとめました.
主要な成果:
- COPD患者におけるICSと骨の健康に関する結果は異なった結果でした.
- いくつかの研究では,ICSで骨粗鬆症と骨折のリスクが投与量に依存して増加することが示された.
- 高用量および長期のICS使用は,特に高齢者および女性患者でリスク増加と関連していました.
結論:
- COPDにおけるICSと骨の健康との関係は複雑です.
- 個別化された治療と骨の保護戦略の検討は,長期または高用量ICSで高リスクの患者にとって極めて重要です.
- 強力な定量合成のために,将来の研究において標準化された定義が必要である.
関連する概念動画
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
2.1K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
2.1K
01:20COPD: Pathogenesis and Clinical Features
2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
01:26COPD: Management Using Bronchodilators and Corticosteroids
1.2K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
01:24Chronic Obstructive Pulmonary Disease
3.0K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K